Royal Brompton and Harefield NHS Foundation Trust

Hugh risebrow 3 x2

How much could private units contribute to NHS financial recovery?

While there are undoubtedly opportunities for private patient units, careful market due diligence needs to be undertaken and the optimal strategy needs to be considered to make them more lucrative. By Hugh Risebrow

Colin Leys

Treating private patients in NHS hospitals – benefit or cost?

An independent investigation is needed into whether trusts are getting significant net additions to their income from treating private patients, and whether the drive to set aside yet further beds for private patients should be allowed to continue. By Colin Leys

Tim Briggs

Specialist hospitals leading the way in innovation

Meet the financial challenge facing NHS

A spoon with tablets on it

The relationship between pharma and the NHS is challenging, not cosy

The three-cornered partnership between the NHS, pharma and academic medicine can only benefit from a more open culture, says Timothy Evans.

Ben Clover

Academic health science partnerships take shape in London

Lord Darzi’s phoenix-from-the-ashes academic health science partnership Imperial Health Partners has got off to a flying start, but one name was conspicuous by its absence on its list of potential partners.

Ben Clover

Reconfiguration threatening to derail London service level agreements

No sooner were service level agreements more or less signed off by London acutes and commissioners, than reconfiguration issues reared their head.